{"id":3321,"date":"2023-02-21T11:29:15","date_gmt":"2023-02-21T03:29:15","guid":{"rendered":"https:\/\/www.hibiki-path-advisors.com\/?p=3321"},"modified":"2023-02-24T06:34:41","modified_gmt":"2023-02-23T22:34:41","slug":"post-3321","status":"publish","type":"post","link":"https:\/\/www.hibiki-path-advisors.com\/en\/message\/2023\/post-3321\/","title":{"rendered":"16\/Feb\/2023 \u2013 Letter to IHARA SCIENCE CORPORATION"},"content":{"rendered":"<p>Hibiki Path Advisors (\u201cHibiki\u201d or \u201cWe\u201d), a value-oriented engagement investor, sent our formal letter to the board of IHARA SCIENCE CORPORATION (5999) on 16 February 2023 regarding its recently announced MBO (Management Buy-Out) transaction.<\/p>\n<p>This document does not constitute an offer, recommendation or solicitation to buy or sell any security or enter into any other transaction. Hibiki does not purport to provide any investment, financial, legal or other expert advice or recommendation in this document.<\/p>\n<p><a class=\"btn\" href=\"https:\/\/www.hibiki-path-advisors.com\/wp-content\/uploads\/2023\/02\/Ihara-Letter-final-English.pdf\">Letter to IHARA SCIENCE CORPORATION<\/a>\u3000<a class=\"btn\" href=\"https:\/\/www.businesswire.com\/news\/home\/53336037\/en\">BUSINESS WIRE press release<\/a><\/p>\n<p>\u3010Recent Posts\u3011\uff08Only in Japanese\uff09<br \/>\n<a href=\"https:\/\/hibiki-investment-news.com\/eng\/onepoint5999_20220624\/\">24\/Jun\/2022 \u2013 IHARA SCIENCE CORPORATION General Meeting of Shareholders<\/a><br \/>\n<a href=\"https:\/\/hibiki-investment-news.com\/news\/onepoint5999_20220513\/\">13\/May\/2022 \u2013 IHARA SCIENCE CORPORATION Comment of the financial results FY2022<\/a><br \/>\n<a href=\"https:\/\/hibiki-investment-news.com\/eng\/iharascience_20220419\/\">19\/Apr\/2022 \u2013 IHARA SCIENCE CORPORATION Financial comparison with Parker Hannifin Corporation<\/a><br \/>\n<\/p>","protected":false},"excerpt":{"rendered":"\u3072\u3073\u304d\u30fb\u30d1\u30fc\u30b9\u30fb\u30a2\u30c9\u30d0\u30a4\u30b6\u30fc\u30ba\u306f2\u670816\u65e5\u3001\u6295\u8cc7\u5148\u3067\u3042\u308b\u30a4\u30cf\u30e9\u30b5\u30a4\u30a8\u30f3\u30b9\u682a\u5f0f\u4f1a\u793e\uff08\u8a3c\u5238\u30b3\u30fc\u30c95999\uff09\u306e\u53d6\u7de0\u5f79\u4f1a\u306b\u5bfe\u3057\u3001\u4eca\u822c\u767a\u8868\u3055\u308c\u305fMBO\uff08\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30fb\u30d0\u30a4\u30a2\u30a6\u30c8\uff09\u306b\u95a2\u3057\u3001\u4e00\u5c11\u6570\u682a\u4e3b\u3068\u3057\u3066\u306e\u898b\u89e3\u3092\u66f8\u7c21\u306e\u5f62\u3067\u9001\u4ed8\u81f4\u3057\u307e\u3057\u305f\u3002 \u5c1a\u3001\u672c\u66f8\u7c21\u306f\u3001\u7279\u5b9a\u306e\u6709\u4fa1\u8a3c\u5238\u306e\u53d6\u5f97\u306e\u7533\u8fbc\u307f\u306e\u52e7\u8a98\u82e5\u3057\u304f\u306f\u58f2\u8cb7\u306e\u63a8\u5968\u53c8\u306f\u6295\u8cc7\u3001\u6cd5\u52d9\u3001\u7a0e\u52d9\u3001\u4f1a\u8a08\u305d\u306e\u4ed6\u3044\u304b\u306a\u308b\u4e8b\u9805\u306b\u95a2\u3059\u308b\u52a9\u8a00\u3092\u884c\u3046\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002 \u30a4\u30cf\u30e9\u30b5\u30a4\u30a8\u30f3\u30b9\u682a\u5f0f\u4f1a\u793e \u66f8\u7c21\u306e\u9001\u4ed8\u306b\u3064\u3044\u3066\u3000BUSINESS WIRE\u3078\u306e\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9 \u3010\u6700\u8fd1\u306e\u6295\u7a3f\u3011 2022\u5e746\u670824\u65e5 \u30fc \u30a4\u30cf\u30e9\u30b5\u30a4\u30a8\u30f3\u30b9\u682a\u5f0f\u4f1a\u793e \u682a\u4e3b\u7dcf\u4f1a\u306b\u3064\u3044\u3066 2022\u5e745\u670813\u65e5 \u30fc \u30a4\u30cf\u30e9\u30b5\u30a4\u30a8\u30f3\u30b9\u682a\u5f0f\u4f1a\u793e \u6c7a\u7b97\u30b3\u30e1\u30f3\u30c8 2022\u5e744\u670819\u65e5 \u30fc \u30a4\u30cf\u30e9\u30b5\u30a4\u30a8\u30f3\u30b9\u682a\u5f0f\u4f1a\u793e \u30d1\u30fc\u30ab\u30fc\u30cf\u30cd\u30d5\u30a3\u30f3\u3068\u306e\u8ca1\u52d9\u6bd4\u8f03\u306b\u3064\u3044\u3066Hibiki Path Advisors (\u201cHibiki\u201d or \u201cWe\u201d), a value-oriented engagement investor, sent our formal letter to the board of IHARA SCIENCE CORPORATION (5999) on 16 February 2023 regarding its recently announced MBO (Management Buy-Out) transaction. This document does not constitute an offer, recommendation or solicitation to buy or sell any security or enter into any other transaction. Hibiki does not purport to provide any investment, financial, legal or other expert advice or recommendation in this document. Letter to IHARA SCIENCE CORPORATION\u3000BUSINESS WIRE press release \u3010Recent Posts\u3011\uff08Only in Japanese\uff09 24\/Jun\/2022 \u2013 IHARA SCIENCE CORPORATION General Meeting of Shareholders 13\/May\/2022 \u2013 IHARA SCIENCE CORPORATION Comment of the financial results FY2022 19\/Apr\/2022 \u2013 IHARA SCIENCE CORPORATION Financial comparison with Parker Hannifin Corporation","protected":false},"author":6,"featured_media":532,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37,55,39],"tags":[],"class_list":{"0":"post-3321","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-37","8":"category-55","9":"category-engagement"},"views":10135,"_links":{"self":[{"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/posts\/3321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/comments?post=3321"}],"version-history":[{"count":6,"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/posts\/3321\/revisions"}],"predecessor-version":[{"id":3332,"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/posts\/3321\/revisions\/3332"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/media\/532"}],"wp:attachment":[{"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/media?parent=3321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/categories?post=3321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hibiki-path-advisors.com\/en\/wp-json\/wp\/v2\/tags?post=3321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}